Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients
- Institution
- ADDINEX TECHNOLOGIES, INC., NY
- Principal investigator
- Stanislav Roslyakov
- Funding
- $7K
- Duration
- 2024–2025
Moonbase score
Still being scored
Abstract
SUMMARY Addinex is seeking to file for a new patent and trademarks to help commercialize our product. Patent: Addinex’s IP attorney will ascertain the patentability of our invention, including showing that it is useful, innovative, novel, and non-obvious, create, document, and file all applicable application documents, including descriptions, claims, drawings, and other forms, perform patent research, both in the United States and in foreign countries, regarding the existence of potential patent infringements, file the provisional patent application, and deal with USPTO examiners during the application examination process. Trademark: Addinex’s IP attorney will search for similar trademarks that could prevent ours from being registered or used in commerce, interpret the results of such findings and advise us on how to proceed, evaluate the strength of our proposed mark and help us develop a strong mark, explain our rights concerning the registered mark and how to pursue infringement claims, prepare and file the trademark application and follow it throughout the process should it require amendment, follow up on the process, adhere to deadlines, check status, and respond to any further inquiries regarding our application. Timeline and Milestones: We plan to file both our new provisional patent and trademarks by year-end. With both in place, our products and brand will be more protected as we transition to commercializing our product and speak with investors.
LOADING MOONBASE SCORE
Questions for Addinex Technologies, Inc.
Addinex Technologies, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same topic, scored first.
- NIH · Addinex Technologies, Inc.Not yet scored
Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder
Stanislav Roslyakov · $307K · 2025–2026
- NSF · Stanford UniversityNot yet scored
How the Dynamics between Inventors and Patent Examiners Determines Innovation
Daniel Mcfarland · $280K · 2025–2028
- NIH · Johns Hopkins UniversityNot yet scored
Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes
Meghan Bridgid Moran · $721K · 2024–2029